Trending...
- BKM's Senior Managing Director of Operations, Susan Rounds, and Associate Director of Design, Koren Mercer, Honored as 2025 Women of Influence - 110
- California: TOMORROW: Governor Newsom joins CAL FIRE to announce an expansion of world's largest aerial firefighting force - 104
- Snell & Wilmer Partner Keith Gregory Named a Top 100 Lawyer & Champion of Mentorship by the LABJ
Patient-founded nonprofit seeks to stimulate innovative research to improve outcomes for patients with ROS1+ cancers.
SACRAMENTO, Calif. - Californer -- The ROS1ders is pleased to issue their annual Request for Application (RFA) to study ROS1-positive (ROS1+) cancer.
"ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer and other types of cancer," said Janet Freeman-Daily, MS, co-founder and president of The ROS1ders. "While oral targeted therapies are approved to treat it, the drugs don't work for everyone, and they eventually stop working. We need more research to learn more about ROS1 biology, find better treatments, and improve quality of life and survival for all patients with this disease."
In its third year, the ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward research projects focused on ROS1+ cancer. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research and is open to investigators who hold a doctorate degree (or equivalent) and a faculty appointment at an academic or non-profit research institution anywhere in the world. The ROS1ders plan to support three seed grant projects in 2025.
More on The Californer
"Seed grants, as the name suggests, allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the real seeds of breakthroughs."
The award program uses a two-step application process. An applicant must first submit a letter of intent (LOI) due March 17, 2025. A subset of those applicants will be invited to submit a full application due June 23, 2025. Award recipients will be announced in early fall. For more information, visit https://theros1ders.org/seed-grant-program.
About the ROS1ders
The ROS1ders, Inc. is a non-profit public benefit corporation that brings together a global group of patients and their family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Founded in 2015 by ROS1+ lung cancer patients, it is the largest collection of ROS1+ patients and caregivers in the world, with hundreds of members from dozens of countries. The organization is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Please visit theros1ders.org to learn more.
More on The Californer
"ROS1+ cancer is relatively rare, occurring in just 1-2% of non-small cell lung cancer and other types of cancer," said Janet Freeman-Daily, MS, co-founder and president of The ROS1ders. "While oral targeted therapies are approved to treat it, the drugs don't work for everyone, and they eventually stop working. We need more research to learn more about ROS1 biology, find better treatments, and improve quality of life and survival for all patients with this disease."
In its third year, the ROS1+ Cancer Innovation Award aims to fund high-risk, high-reward research projects focused on ROS1+ cancer. The one-year $75,000 seed grant can be used for pre-clinical, translational, or clinical research and is open to investigators who hold a doctorate degree (or equivalent) and a faculty appointment at an academic or non-profit research institution anywhere in the world. The ROS1ders plan to support three seed grant projects in 2025.
More on The Californer
- Kavelle Christie: Trump's First 100 Days Mark Alarming Breakdown in Healthcare, Public Health, and Freedoms
- California: TOMORROW: Governor Newsom to announce first-in-the-nation government efficiency efforts
- VCCCD Marketing Teams Honored in Public Relations Awards Ceremony
- BD&J Injury Lawyers Bolsters Leadership with Advancement of Eleven Junior Partners
- City of Long Beach Commemorates Demolition of English Village Near Queen Mary
"Seed grants, as the name suggests, allow for the generation of initial data to support larger research endeavors," said D. Ross Camidge, MD, PhD, Professor of Medicine/Oncology at the University of Colorado and a member of The ROS1ders Scientific Advisory Board. "While some seeds fail, others grow into mighty trees - they can be the real seeds of breakthroughs."
The award program uses a two-step application process. An applicant must first submit a letter of intent (LOI) due March 17, 2025. A subset of those applicants will be invited to submit a full application due June 23, 2025. Award recipients will be announced in early fall. For more information, visit https://theros1ders.org/seed-grant-program.
About the ROS1ders
The ROS1ders, Inc. is a non-profit public benefit corporation that brings together a global group of patients and their family members living with ROS1+ cancer. It seeks to improve outcomes for all ROS1+ cancers through community, education, and research. Founded in 2015 by ROS1+ lung cancer patients, it is the largest collection of ROS1+ patients and caregivers in the world, with hundreds of members from dozens of countries. The organization is internationally recognized in the oncology and patient advocacy communities as experts in their disease. Please visit theros1ders.org to learn more.
More on The Californer
- California: Governor Newsom proclaims Workers' Memorial Day 2025
- Angelo Ponzi Debuts Heartfelt New Album "Lover of Country Music", Now Available Worldwide
- Flexi-View Lending Closes $9 Million Construction Loan for New Hotel Development
- Inaugural Venice Beach Half Marathon & 5K to Debut on Sunday, May 18, 2025
- Beyond Words: Why Hollywood's Success Hinges on True Localization, Not Just Translation
Source: The ROS1ders
0 Comments
Latest on The Californer
- Mensa identifies best board games of 2025
- WELLFIT Releases New Incline Walking Pad–A Game-Changer for At-Home Fitness
- May Is Deck Safety Month, Get Your Deck Inspected for Only $200, Regularly $350
- Abbott Highlights New AVEIR™ Data, Initiates Trial for the Company's Conduction System Pacing Technology
- City of Long Beach Issues Rain Advisory Due to Recent Showers
- New Clinical Study Data Showcase Long-Term, Sustained Benefits of Abbott's Volt™ PFA System for Patients with AFib USA - English USA - English
- Soccer Soar USA Launches in Los Angeles: Ultimate Soccer Magazine Kicks Off with First Issue
- California: Governor Newsom on new DOGE action to dismantle AmeriCorps: 'We will serve the federal government with a lawsuit'
- Costa Rica's Rainy Season Brings a Surge in Sportfishing Action and Travel Deals
- California: Governor Newsom announces appointments 4.25.25
- California exceeds 4 million MyShake app downloads, urges Californians to take preparedness steps
- Medtronic receives FDA approval for smallest-diameter, lumenless defibrillation lead, the OmniaSecure™ lead and announces investigational clinical study results
- California, federal government, Yuba Water Agency partner up in historic project to reopen North Yuba River to native fish
- People & Stories/Gente y Cuentos Announces New Board Leadership & Corporate Partnership Initiative
- What People Are Saying About ZIBA
- Blue Wolf Interactive Reveals Critical Strategies for Local Businesses to Dominate Near Me Searches
- Breaking Celebrity News Actor/Influencer Andre Swilley to Attend World Premier of "Thunderbolts"
- Long Beach Parks, Recreation and Marine to Offer a Variety of Recreation Classes This Summer
- My Community Health Fair presents the second annual DTLA Spring Health Fair
- InventHelp Inventor Develops New Automatic Landing Gear Crank (SBM-175)